PB
Philip Bufler

Elite Scholar


168
Works
7,779
Citations
43
H-Index
Search Authors
Author Statistics

Philip Bufler

Also known as: Bufler, P., Bufler, Philip, P Bufler, P. BUFLER, P. Bufler

168

Total Works

7,779

Citations

43

H-Index

78

i10-Index

Citation & Works Trend by Year
29 years active
Top Research Topics
Cytokine Signaling Pathways and Interactions (35) Immune Response and Inflammation (32) Inflammatory Bowel Disease (30) Pediatric Hepatobiliary Diseases and Treatments (29) IL-33, ST2, and ILC Pathways (27)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Lymphatic Dysplasia Shapes Liver Epithelial Outcomes in Biliary Atresia medRxiv 0
2026 Post-exposure prophylaxis with a monoclonal antibody cocktail after Bundibugyo ebolavirus exposure in adults and children Nature Medicine 0
2026 Subcutaneous infliximab as a maintenance option in pediatric IBD: a real-world cohort including younger and lower-weight children Molecular and Cellular Pediatrics 3
2026 Additional file 1 of Subcutaneous infliximab as a maintenance option in pediatric IBD: a real-world cohort including younger and lower-weight children Figshare 0
2026 Subcutaneous infliximab as a maintenance option in pediatric IBD: a real-world cohort including younger and lower-weight children Figshare 0
2026 Kidney-specific Wdr72 deletion leads to incomplete distal renal tubular acidosis through impaired V-ATPase B1 subunit localization Genes & Diseases 0
2026 Untitled PubMed 0
2026 S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Genetisch-cholestatische Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) Zeitschrift für Gastroenterologie 1
2026 Update der S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Living guideline Zeitschrift für Gastroenterologie 2
2026 WED-302 Multimodal definition of the cytokine milieu predicting impaired jaundice clearance in biliary atresia Journal of Hepatology 0
2026 TOP-311 Lymphatic endothelium reprograms cholangiocytes in biliary atresia Journal of Hepatology 0
2026 FRI-301 Setting-up a biliary niche-on-a-chip for the study of human liver disease-associated ductular reaction Journal of Hepatology 0
2026 Ustekinumab therapy for moderately to severely active pediatric Crohn’s disease: UNITI Jr study safety and efficacy results in patients weighing at least 40 kg Journal of Crohn s and Colitis 2
2026 Update in clinical science: MASLD in children and adolescents Journal of Hepatology 16
2026 Einflussfaktoren auf Beginn und Progression der Leberbeteiligung bei Kindern mit Mukoviszidose Klinische Pädiatrie 0

Data source: OpenAlex API